PresentationLadies and gentlemen, thank you for standing by. My name is Krista, and I will be your conference operator today. At this time, I would like to welcome everyone to the BridgeBio Pharma Autosomal Dominant Hypocalcemia Type 1 ADH1 CALIBRATE Phase III top line results webinar [Operator Instructions] I would now like to turn the conference over to Dr. Neil Kumar, Chief Executive Officer. Dr. Kumar, please go ahead.Neil KumarCo-Founder, CEO & Director Thank you to everyone who joined this call, parti ...